Morgan Stanley on Rocket Pharmaceuticals (RCKT): approval marks 'positive readthrough to broader pipeline'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. META
4. ABBV
5. MU
6. SPY
7. ACN
8. BLZE
9. IBM
10. NKE

Go back to Morgan Stanley on Rocket Pharmaceuticals (RCKT): approval marks 'positive readthrough to broader pipeline'
(NASDAQ: RCKT) Delayed: 3.47 --0 (-0%)
Previous Close $3.47    52 Week High $ 
Open $3.47    52 Week Low $ 
Day High $3.47    P/E N/A 
Day Low $3.47    EPS $ 
Volume 4